<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteMedicine &#8211; Wyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 17 Sep 2026 20:34:04 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/discipline/medicine/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>Building big with DNA gets a software upgrade</title>
				<link>https://wyss.harvard.edu/news/building-big-with-dna-gets-a-software-upgrade/</link>
        <pubDate>Wed, 16 Sep 2026 13:55:09 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[DNA assembly]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=46184</guid>
                            <description>New computational framework for crisscross fabrication of micrometer-scale DNA megastructures with nanoscale precision broadens accessibility to this powerful nanotechnology</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; 44 years ago, Nadrian Seeman published his groundbreaking ideas on using DNA as a structural material, expanding DNA&rsquo;s significance way beyond that as a carrier of genetic information. Since then, the steadily growing field of DNA nanotechnology has seen numerous innovations. One of them was the DNA origami technique, which enables researchers to fold a single&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/building-big-with-dna-gets-a-software-upgrade/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/building-big-with-dna-gets-a-software-upgrade/</link>
          <title>The team used their easily accessible computational framework, #-CAD, to design and fabricate a series of complex Crisscross DNA megastructures from start to finish. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/09/14094955/Crisscross_listing-image.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=84351ede948e19b68f2dc6ce79cd8d84"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Awarded ARPA-H Contract to End the Guesswork in Fetal Distress</title>
				<link>https://wyss.harvard.edu/news/wyss-awarded-arpa-h-contract-to-end-the-guesswork-in-fetal-distress/</link>
        <pubDate>Tue, 08 Sep 2026 13:30:02 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[ARPA-H]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[David R. Walt]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[Massachusetts General Hospital]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=46142</guid>
                            <description>Cross-faculty lab collaborative team to develop molecular oxygen-sensing technology for fetal health monitoring during labor</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Awarded a contract for up to $12M from the Advanced Research Projects Agency for Health (ARPA&#x2d;H), researchers at the Wyss Institute at Harvard University, across several of its Technology Platforms and faculty labs, have joined forces to address a critical unmet need in maternal and women&rsquo;s health: clinicians&rsquo; inadequate ability to monitor oxygen support of&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/wyss-awarded-arpa-h-contract-to-end-the-guesswork-in-fetal-distress/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/wyss-awarded-arpa-h-contract-to-end-the-guesswork-in-fetal-distress/</link>
          <title>Clinicians ability to monitor oxygen support of fetuses during labor is extremely inadequate. This is critical because insufficient oxygen support of unborn babies significantly increases the risks for infant and maternal health. With support from a newly awarded contract from the ARPA-H MOCS program, researchers at the Wyss Institute at Harvard University across several of its Technology Platforms and faculty labs join forces to address this critical unmet need in maternal and women’s health. Credit: Envato / Lobachad</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/09/03132817/newborn-infant-examined-by-healthcare-provider-in-2026-03-24-23-33-31-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=14adb1a89fadb2a814fda82749b8239e"/></url>
				</image>
        			</item>

		
			<item>
				<title>Researchers clear major obstacle in genetic engineering of proteins</title>
				<link>https://wyss.harvard.edu/news/researchers-clear-major-obstacle-in-genetic-engineering-of-proteins/</link>
        <pubDate>Wed, 26 Aug 2026 15:13:59 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=46074</guid>
                            <description>Unexpected discovery about tRNAs leads to tool that can drive faster, safer production of new medicines</description>
                                        <content:encoded><![CDATA[<p>By STEPHANIE DUTCHEN / Harvard Medical School Communications (BOSTON) &mdash; Scientists have been hard at work for more than 20 years to instruct biological systems, such as E. coli cells, to produce proteins they don&rsquo;t naturally do. Success could mean faster, cheaper, innovative solutions for medicine, agriculture, materials science, environmental remediation, and other industries.</p>
<p><a href="https://wyss.harvard.edu/news/researchers-clear-major-obstacle-in-genetic-engineering-of-proteins/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/researchers-clear-major-obstacle-in-genetic-engineering-of-proteins/</link>
          <title>Researchers at the Wyss Institute and Harvard Medical School have engineered the code that to synthesize proteins from RNA to accommodate 34 instead of the usual 20 amino acid building blocks. This enables the creating of proteins with new functions and with potential for diverse applications in medicine and biomedical research.  Credit: filo/Getty Images Plus</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/08/26111717/848-abstract-vertical-colorful-bars.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c20dffa01d3cc8fef1db27db20e786d1"/></url>
				</image>
        			</item>

		
			<item>
				<title>Buying time: A medical breakthrough in stroke treatment</title>
				<link>https://wyss.harvard.edu/media-post/buying-time-a-medical-breakthrough-in-stroke-treatment/</link>
        <pubDate>Wed, 12 Aug 2026 13:33:27 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Brain Health]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=45990</guid>
                                                <content:encoded><![CDATA[<p>When a stroke strikes, every minute matters. Science has traditionally approached stroke as a race against time. But rather than racing faster, what if we could instead slow the damage down? Join host Shahni Wellington as she explores groundbreaking research aimed at buying more time for stroke patients, particularly those in rural and regional communities. In this episode, she talks with Dr.</p>
<p><a href="https://wyss.harvard.edu/media-post/buying-time-a-medical-breakthrough-in-stroke-treatment/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/buying-time-a-medical-breakthrough-in-stroke-treatment/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/08/12093109/LiSTNR_The-Minds-Changing-Lives_App-Square_3000x3000-scaled-e1786541489172.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=a2300aba390a5577790d4144f35171f6"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute receives Massachusetts Life Science Center award to advance metabolomics and lipidomics research across Massachusetts ecosystem</title>
				<link>https://wyss.harvard.edu/news/wyss-institute-receives-massachusetts-life-science-center-award-to-advance-metabolomics-and-lipidomics-research-across-massachusetts-ecosystem/</link>
        <pubDate>Wed, 22 Jul 2026 14:03:23 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[David R. Walt]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[Michael Levin]]></category>
		<category><![CDATA[Scientific Instrumentation Program]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45816</guid>
                            <description>Award enables unprecedented instrument capabilities at the Institute, facilitating collaborative research across many areas of human and environmental health</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The Wyss Institute at Harvard University has received an award from the Massachusetts Life Science Center (MLSC), enabling it to host a next&#x2d;generation metabolomics and lipidomics analytical platform. The platform will allow its researchers to creatively pursue new approaches to biomarker and drug discovery across multiple health challenges the Institute is&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/wyss-institute-receives-massachusetts-life-science-center-award-to-advance-metabolomics-and-lipidomics-research-across-massachusetts-ecosystem/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/wyss-institute-receives-massachusetts-life-science-center-award-to-advance-metabolomics-and-lipidomics-research-across-massachusetts-ecosystem/</link>
          <title>During the MLSC’s award ceremony at the Wyss Institute, MLSC President and CEO Kirk Taylor (shown on this photo) and the MLSC team announced $19.7M in funding to support 23 projects, one of which is hosted by the Wyss Institute now. Credit: Massachusetts Life Science Center</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/07/21111648/MLSC-Wyss-Institute-Event-9063-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=379e9b74e7b11b351d0682acd4149e6f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Recapitulating intramuscular vaccination with mRNA vaccines in patient-specific Lymphoid Organ Chips</title>
				<link>https://wyss.harvard.edu/news/recapitulating-intramuscular-vaccination-with-mrna-vaccines-in-patient-specific-lymphoid-organ-chips/</link>
        <pubDate>Fri, 17 Jul 2026 13:55:40 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Immune System]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45749</guid>
                            <description>Expanded Lymphoid Organ Chip model captures mRNA vaccination from injection to protective antibody production with unprecedented complexity, with unique potential for mRNA vaccine research</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The protective abilities of the Moderna and BioNTech mRNA vaccines developed against COVID&#x2d;19 saved millions of lives during the pandemic and put this platform technology in the spotlight of vaccine research. By now, mRNA vaccines for other infectious diseases, such as influenza, RSV, and HIV are being tested in clinical trials and highly anticipated.</p>
<p><a href="https://wyss.harvard.edu/news/recapitulating-intramuscular-vaccination-with-mrna-vaccines-in-patient-specific-lymphoid-organ-chips/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/recapitulating-intramuscular-vaccination-with-mrna-vaccines-in-patient-specific-lymphoid-organ-chips/</link>
          <title>A cross-organizational research collaboration led by Wyss Director in Bioinspired Therapeutics Girija Goyal, Ph.D., and Wyss Founding Director and Bioinspired Therapeutics Lead Donald Ingber, M.D., Ph.D. has now developed an all-human alternative for evaluating vaccine-induced immunity with vast potential for guiding mRNA vaccine developments for multiple infectious diseases. Credit: Envato</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/07/15124540/adult-receives-an-injection-in-upper-arm-2026-03-25-01-13-28-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=ac0ba85df94c5aeecfde0c64fe67c9ea"/></url>
				</image>
        			</item>

		
			<item>
				<title>Machine-learning how to overcome antibiotic-resistant gonorrhea</title>
				<link>https://wyss.harvard.edu/news/machine-learning-how-to-overcome-antibiotic-resistant-gonorrhea/</link>
        <pubDate>Wed, 17 Jun 2026 17:55:26 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Antibiotic Resistance]]></category>
		<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[MIT]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45581</guid>
                            <description>AI-enabled antibiotic discovery proves effective at identifying new chemical structures and targets in the constant fight against antibiotic-resistant gonorrhea</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; With tens of millions of annual cases, gonorrhea is the second most frequently reported sexually transmitted infection (STI). In the U.S. alone, over 600,000 cases are reported each year. If left untreated, gonorrhea can result in severe reproductive health issues, including infertility in both women and men, and pelvic inflammatory disease.</p>
<p><a href="https://wyss.harvard.edu/news/machine-learning-how-to-overcome-antibiotic-resistant-gonorrhea/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/machine-learning-how-to-overcome-antibiotic-resistant-gonorrhea/</link>
          <title>Gonorrhea, which is caused by the bacterial pathogen Neisseria gonorrhoeae, is one of the most-often occurring sexually transmitted infections resulting in a plethora of health issues. Credit: Shutterstock/ESB Professional</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/06/16140539/shutterstock_1174971127-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=13990ec92c8d828d0baec3c7a1739c71"/></url>
				</image>
        			</item>

		
			<item>
				<title>Decoding inflammatory bowel disease – on a chip</title>
				<link>https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/</link>
        <pubDate>Thu, 21 May 2026 09:30:43 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Gut-on-a-Chip]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Inflammation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45488</guid>
                            <description>Replication of patient- and sex-specific hallmarks of IBD in a human organ chip reveals stromal fibroblasts as drivers of inflammation, fibrosis, and enhanced cancer risk</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn&rsquo;s disease and ulcerative colitis, affects about 1.6 million Americans, many of whom cannot be effectively treated. This is mostly due to a lack of understanding of what exactly causes the increased inflammation, fibrosis, and compromised intestinal barrier that underlie this&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/decoding-inflammatory-bowel-disease-on-a-chip/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/05/20121105/Colon-Chip.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c60ba1aa68dd5c86bf69c58c19a8c841"/></url>
				</image>
        			</item>

		
			<item>
				<title>Multidisciplinary Wyss team receives 2026 Lush Prize Science Award</title>
				<link>https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/</link>
        <pubDate>Mon, 18 May 2026 18:30:48 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biosensors]]></category>
		<category><![CDATA[Boston Children's Hospital]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45467</guid>
                            <description>Recognition highlights the growing impact of Organ Chip technology in reducing animal testing in biomedical and women’s health research</description>
                                        <content:encoded><![CDATA[<p>(BOSTON) &mdash; The Wyss Institute for Biologically Inspired Engineering at Harvard University is proud to announce that the Biosensing, Microfluidics, and Microsystems team, led by Wyss Senior Engineer Adama Sesay, Ph.D., together with the Female Reproductive Health team, has received the 2026 Lush Science Prize. The prize recognizes their work developing next&#x2d;generation, sensor&#x2d;integrated human Organ&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/multidisciplinary-wyss-team-receives-2026-lush-prize-science-award/</link>
          <title>Wyss Research Scholar Zoheh Izadifar (left), a former Postdoctoral Fellow in the lab of Wyss Founding Director Donald Ingber, and now an Assistant Professor at Boston Children’s Hospital and Harvard Medical School, received the award on behalf of the Wyss teams during the Lush Prize award ceremony, held and livestreamed on May 12 in London. This photo shows her next to jury member Ellen Fritsche (right), Director of the Swiss Centre for Applied Human Toxicology (SCAHT) affiliated to the University of Basel. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/05/18113142/Zohreh-Izadifar-Science-LP26_Ellen-Fritsche-scaled-e1779118388548.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=a7846fa4b4163e138d93bb0cd4969b75"/></url>
				</image>
        			</item>

		
			<item>
				<title>Materializing safe, on-demand living therapeutics</title>
				<link>https://wyss.harvard.edu/news/materializing-safe-on-demand-living-therapeutics/</link>
        <pubDate>Thu, 14 May 2026 17:55:55 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Anti-aging]]></category>
		<category><![CDATA[Autoimmune Diseases]]></category>
		<category><![CDATA[Biological Materials]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biosafety]]></category>
		<category><![CDATA[Biosensors]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Gene Regulation]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Healthy Aging]]></category>
		<category><![CDATA[Hydrogel]]></category>
		<category><![CDATA[Implants]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45432</guid>
                            <description>Generalizable framework for Implantable Living Materials composed of highly engineered hydrogels and synthetically engineered bacteria opens diverse novel therapeutic avenues</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Patient recovery from many debilitating conditions and diseases could be sped up significantly and be more effective if drugs and therapeutic molecules were delivered right to where they are needed in the body, over the entire regenerative process, and in doses finely tuned to therapeutic needs. An intriguing way to achieve this is the use of implantable&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/materializing-safe-on-demand-living-therapeutics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/materializing-safe-on-demand-living-therapeutics/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/05/14094243/Listing-Image-Time-Lapse-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=ea17a211bb1a4b414c8bfecb0d32931a"/></url>
				</image>
        			</item>

			</channel>
</rss>
